Patient-reported Outcomes With Bifeprunox or Olanzapine in the Treatment of Schizophrenia. A Pharmacoeconomic Study Carried Out in Connection With the S1543003 And S1543004 Clinical Trials
Phase of Trial: Phase III
Latest Information Update: 11 Sep 2013
At a glance
- Drugs Bifeprunox; Olanzapine
- Indications Schizophrenia
- Focus Therapeutic Use
- 05 Sep 2013 Actual end date (Jan 2007) added as reported by ClinicalTrials.gov.
- 07 Sep 2007 Status changed from in progress to completed.
- 05 Nov 2005 New trial record.